Correlation Between Achilles Therapeutics and Instil Bio

Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Achilles Therapeutics PLC and Instil Bio, you can compare the effects of market volatilities on Achilles Therapeutics and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Instil Bio.

Diversification Opportunities for Achilles Therapeutics and Instil Bio

0.04

Correlation Coefficient

Achilles Therapeutics  Instil Bio

Significant diversification

The 3 months correlation between Achilles and Instil is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Instil Bio go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Instil Bio

Given the investment horizon of 90 days Achilles Therapeutics is expected to generate 2.77 times less return on investment than Instil Bio. But when comparing it to its historical volatility, Achilles Therapeutics PLC is 3.6 times less risky than Instil Bio. It trades about 0.16 of its potential returns per unit of risk. Instil Bio is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1,393  in Instil Bio on September 2, 2024 and sell it today you would earn a total of  1,298  from holding Instil Bio or generate 93.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Achilles Therapeutics PLC  vs.  Instil Bio

Achilles Therapeutics PLC

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Instil Bio

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Achilles Therapeutics and Instil Bio

The main advantage of trading using opposite Achilles Therapeutics and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.

The idea behind Achilles Therapeutics PLC and Instil Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.